Free Trial

Mplx (MPLX) Financials

Mplx logo
$49.44 -0.56 (-1.12%)
Closing price 03:59 PM Eastern
Extended Trading
$49.73 +0.29 (+0.59%)
As of 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Mplx

Annual Income Statements for Mplx

This table shows Mplx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
121 156 658 1,047 1,743 935 -206 3,077 3,815 3,829 4,290
Consolidated Net Income / (Loss)
239 333 900 836 2,006 1,462 -687 3,112 3,978 3,966 4,357
Net Income / (Loss) Continuing Operations
239 333 900 836 2,006 1,462 -51 3,112 3,978 3,966 4,357
Total Pre-Tax Income
240 334 422 837 2,014 1,462 -685 3,113 3,986 3,977 4,367
Total Operating Income
245 381 916 1,191 2,728 2,377 211 3,992 4,911 4,900 5,288
Total Gross Profit
411 650 1,914 2,169 4,129 5,329 7,276 5,794 6,591 6,623 7,129
Total Revenue
793 1,101 3,029 3,867 7,005 9,041 9,141 10,027 11,613 11,281 11,933
Operating Revenue
787 1,101 3,029 3,867 6,998 9,041 9,141 10,027 11,613 11,281 11,933
Total Cost of Revenue
382 451 1,115 1,698 2,876 3,712 1,865 4,233 5,022 4,658 4,804
Operating Cost of Revenue
382 451 1,115 1,698 2,876 3,712 1,865 4,233 5,022 4,658 4,804
Total Operating Expenses
166 269 998 978 1,401 2,952 5,493 1,802 1,680 1,723 1,841
Selling, General & Admin Expense
81 125 227 241 316 388 378 353 335 379 427
Depreciation Expense
75 129 591 683 867 1,254 1,377 1,287 1,230 1,213 1,283
Other Operating Expenses / (Income)
10 15 50 54 218 113 1,536 120 115 131 131
Total Other Income / (Expense), net
-5.00 -47 -28 -354 -714 -915 -1,832 -879 -925 -923 -921
Interest Expense
4.00 35 211 298 595 862 896 793 925 923 921
Income Tax Expense
1.00 1.00 -12 1.00 8.00 0.00 2.00 1.00 8.00 11 10
Preferred Stock Dividends Declared
0.00 0.00 41 65 75 98 122 141 129 99 27
Net Income / (Loss) Attributable to Noncontrolling Interest
57 1.00 2.00 6.00 16 28 33 35 34 38 40
Basic Earnings per Share
$3.05 $1.34 $0.00 $1.07 $2.29 $1.00 ($0.80) $2.86 $3.75 $3.80 $4.21
Weighted Average Basic Shares Outstanding
76M 99M 676M 786M 1.52B 906M 1.05B 1.03B 1.01B 1.00B 1.02B
Diluted Earnings per Share
$3.05 $1.33 $0.00 $1.06 $2.29 $1.00 ($0.80) $2.86 $3.75 $3.80 $4.21
Weighted Average Diluted Shares Outstanding
76M 100M 690M 792M 1.52B 907M 1.05B 1.03B 1.01B 1.00B 1.02B
Weighted Average Basic & Diluted Shares Outstanding
76M 99M 338M 393M 761M 906M 1.05B 1.03B 1.01B 1.00B 1.02B
Cash Dividends to Common per Share
$1.41 - - - - - $2.75 $3.36 $2.96 $3.25 $3.61

Quarterly Income Statements for Mplx

This table shows Mplx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
783 915 910 893 1,111 995 1,171 1,031 1,093 1,126 1,048
Consolidated Net Income / (Loss)
824 952 942 928 1,144 1,015 1,186 1,047 1,109 1,136 1,058
Net Income / (Loss) Continuing Operations
824 952 942 928 1,144 1,015 1,186 1,047 1,109 1,136 1,058
Total Pre-Tax Income
826 953 942 929 1,153 1,016 1,188 1,049 1,114 1,137 1,059
Total Operating Income
1,060 1,196 1,175 1,154 1,375 1,251 1,419 1,275 1,343 1,366 1,293
Total Gross Profit
436 1,972 2,313 1,601 737 2,082 2,263 1,736 667 2,226 2,125
Total Revenue
2,662 2,713 2,690 2,912 2,966 2,846 3,052 2,972 3,063 3,124 3,003
Operating Revenue
2,662 2,713 2,690 2,912 2,966 2,846 3,052 2,972 3,063 3,124 3,003
Total Cost of Revenue
2,226 741 377 1,311 2,229 764 789 1,236 2,396 898 878
Operating Cost of Revenue
2,226 741 377 1,311 2,229 764 789 1,236 2,396 898 878
Total Operating Expenses
-624 776 1,138 447 -638 831 844 461 -676 860 832
Selling, General & Admin Expense
87 89 89 102 99 109 107 107 104 112 107
Depreciation Expense
305 296 310 301 306 317 320 322 324 326 324
Other Operating Expenses / (Income)
-1,016 391 739 44 -1,043 405 417 32 -1,104 422 401
Total Other Income / (Expense), net
-234 -243 -233 -225 -222 -235 -231 -226 -229 -229 -234
Interest Expense
253 243 233 225 222 235 231 226 229 229 234
Income Tax Expense
2.00 1.00 0.00 1.00 9.00 1.00 2.00 2.00 5.00 1.00 1.00
Preferred Stock Dividends Declared
33 28 23 25 23 10 5.00 6.00 6.00 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
8.00 9.00 9.00 10 10 10 10 10 10 10 10
Basic Earnings per Share
$0.78 $0.91 $0.91 $0.89 $1.09 $0.98 $1.15 $1.01 $1.07 $1.10 $1.03
Weighted Average Basic Shares Outstanding
1.01B 1.00B 1.00B 1.00B 1.00B 1.01B 1.02B 1.02B 1.02B 1.02B 1.02B
Diluted Earnings per Share
$0.78 $0.91 $0.91 $0.89 $1.09 $0.98 $1.15 $1.01 $1.07 $1.10 $1.03
Weighted Average Diluted Shares Outstanding
1.01B 1.00B 1.00B 1.00B 1.00B 1.01B 1.02B 1.02B 1.02B 1.02B 1.02B
Weighted Average Basic & Diluted Shares Outstanding
1.01B 1.00B 1.00B 1.00B 1.00B 1.01B 1.02B 1.02B 1.02B 1.02B 1.02B
Cash Dividends to Common per Share
- $0.78 $0.78 $0.85 - $0.85 $0.85 $0.96 - $0.96 $0.96

Annual Cash Flow Statements for Mplx

This table details how cash moves in and out of Mplx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
-27 16 187 -230 76 -70 0.00 -2.00 225 810 471
Net Cash From Operating Activities
334 427 1,491 1,907 3,071 4,082 4,521 4,911 5,019 5,397 5,946
Net Cash From Continuing Operating Activities
334 427 1,491 1,907 3,071 4,082 4,521 4,911 5,019 5,397 5,966
Net Income / (Loss) Continuing Operations
239 333 434 836 2,006 1,462 -687 3,112 3,978 3,966 4,357
Consolidated Net Income / (Loss)
239 333 434 836 2,006 1,462 -687 3,112 3,978 3,966 4,357
Depreciation Expense
75 129 591 683 867 1,254 1,377 1,287 1,230 1,213 1,283
Amortization Expense
1.00 5.00 46 53 55 42 61 70 73 55 54
Non-Cash Adjustments To Reconcile Net Income
-2.00 11 345 161 161 1,425 3,564 216 -373 30 27
Changes in Operating Assets and Liabilities, net
21 -51 75 174 -18 -101 206 226 111 133 245
Net Cash From Investing Activities
-137 -1,686 -1,417 -2,308 -2,878 -3,063 -1,262 -518 -956 -1,252 -1,995
Net Cash From Continuing Investing Activities
-137 -1,686 -1,417 -2,308 -2,878 -3,063 -1,262 -518 -956 -1,252 -1,995
Purchase of Property, Plant & Equipment
-141 -334 -1,313 -1,411 -2,111 -2,408 -1,183 -529 -806 -937 -1,056
Acquisitions
0.00 -1,232 -87 -1,010 -792 -713 -266 -151 -245 -344 -1,086
Sale of Property, Plant & Equipment
0.00 0.00 1.00 7.00 8.00 30 56 126 84 26 1.00
Sale and/or Maturity of Investments
0.00 0.00 0.00 106 16 18 123 36 11 3.00 146
Net Cash From Financing Activities
-224 1,275 113 171 -117 -1,089 -3,259 -4,395 -3,838 -3,335 -3,480
Net Cash From Continuing Financing Activities
-224 1,275 113 171 -117 -1,089 -3,259 -4,395 -3,838 -3,335 -3,480
Repayment of Debt
-529 -1,746 -3,858 -2,440 -11,369 -7,363 -7,043 -12,866 -6,674 -1,018 -1,172
Repurchase of Preferred Equity
- - - - - - - 0.00 0.00 -600 0.00
Repurchase of Common Equity
- - - - 0.00 0.00 -33 -630 -491 0.00 -326
Payment of Dividends
-175 -159 -873 -1,192 -1,907 -3,069 -3,043 -3,612 -3,085 -3,337 -3,647
Issuance of Debt
1,160 1,960 2,966 5,280 17,457 9,174 6,810 12,668 6,368 1,589 1,630
Other Financing Activities, net
-910 -11 96 -2,089 -4,309 74 50 45 44 31 35

Quarterly Cash Flow Statements for Mplx

This table details how cash moves in and out of Mplx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents
117 155 362 205 88 -663 2,116 -75 -907 1,015 -1,148
Net Cash From Operating Activities
1,368 1,227 1,437 1,244 1,489 1,291 1,565 1,415 1,675 1,246 1,736
Net Cash From Continuing Operating Activities
1,368 1,227 1,437 1,244 1,489 1,291 1,585 1,415 1,675 1,246 1,736
Net Income / (Loss) Continuing Operations
824 952 942 928 1,144 1,015 1,186 1,047 1,109 1,136 1,058
Consolidated Net Income / (Loss)
824 952 942 928 1,144 1,015 1,186 1,047 1,109 1,136 1,058
Depreciation Expense
305 296 310 301 306 317 320 322 324 326 324
Amortization Expense
18 17 12 13 13 13 14 14 13 10 6.00
Non-Cash Adjustments To Reconcile Net Income
43 6.00 33 34 -43 3.00 -107 72 59 2.00 37
Changes in Operating Assets and Liabilities, net
178 -44 140 -32 69 -57 172 -40 170 -228 311
Net Cash From Investing Activities
-280 -220 -271 -236 -525 -996 -114 -536 -349 -601 -602
Net Cash From Continuing Investing Activities
-280 -220 -271 -236 -525 -996 -114 -536 -349 -601 -602
Purchase of Property, Plant & Equipment
-271 -169 -263 -230 -275 -255 -213 -280 -308 -267 -301
Acquisitions
-19 -51 -26 -13 -254 -741 -35 -260 -50 -356 -348
Sale and/or Maturity of Investments
- - - - 3.00 0.00 - 4.00 8.00 21 39
Net Cash From Financing Activities
-971 -852 -804 -803 -876 -958 665 -954 -2,233 370 -2,282
Net Cash From Continuing Financing Activities
-971 -852 -804 -803 -876 -958 665 -954 -2,233 370 -2,282
Repayment of Debt
-166 -1,018 -1.00 - 1.00 -6.00 -13 -2.00 -1,151 -525 -1,203
Repurchase of Common Equity
-176 0.00 - - - -75 -75 -76 -100 -100 -100
Payment of Dividends
-808 -831 -808 -810 -888 -887 -885 -884 -991 -989 -987
Issuance of Debt
165 1,589 - - - 0.00 1,630 - - 1,977 1.00
Other Financing Activities, net
14 8.00 5.00 7.00 11 10 8.00 8.00 9.00 7.00 7.00

Annual Balance Sheets for Mplx

This table presents Mplx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
1,214 16,104 17,509 19,500 39,325 40,430 36,414 35,507 35,665 36,529 37,511
Total Current Assets
97 576 868 559 1,440 1,484 1,515 1,507 1,905 2,808 3,276
Cash & Equivalents
27 43 234 5.00 77 15 15 13 238 1,048 1,519
Accounts Receivable
51 432 546 452 611 593 1,129 1,298 1,466 1,571 1,548
Inventories, net
12 51 55 65 98 110 118 142 148 159 180
Other Current Assets
7.00 50 33 37 654 766 66 54 53 30 29
Plant, Property, & Equipment, net
1,008 9,997 11,408 12,187 21,525 22,145 21,218 20,042 0.00 0.00 0.00
Total Noncurrent Assets
109 5,531 5,233 6,754 16,360 16,801 13,912 14,187 33,760 33,721 34,235
Long-Term Investments
0.00 2,458 2,471 4,010 4,901 5,275 4,036 3,981 4,095 3,743 4,531
Goodwill
105 2,570 2,245 2,245 10,016 9,536 7,657 7,657 7,645 7,645 7,645
Intangible Assets
0.00 466 492 453 1,359 1,270 959 831 705 654 518
Other Noncurrent Operating Assets
4.00 12 14 26 84 720 588 557 21,315 21,679 21,541
Total Liabilities & Shareholders' Equity
1,214 16,104 17,509 19,500 39,325 40,430 36,414 35,507 35,665 36,529 37,511
Total Liabilities
751 6,437 5,399 8,527 20,590 22,849 22,429 22,490 22,151 22,945 23,501
Total Current Liabilities
101 625 763 1,304 2,268 2,132 2,086 3,348 2,401 2,624 3,235
Short-Term Debt
- - - - - 9.00 764 499 988 1,135 1,693
Accounts Payable
34 145 227 667 266 242 508 1,952 224 153 147
Accrued Expenses
28 355 378 425 671 470 278 460 397 516 503
Other Current Liabilities
2.00 12 27 81 1,147 1,201 213 235 556 579 648
Other Current Nonoperating Liabilities
1.00 54 53 88 184 210 323 202 237 242 244
Total Noncurrent Liabilities
650 5,812 4,636 7,223 18,322 20,717 20,343 19,142 19,750 20,321 20,266
Long-Term Debt
644 5,255 4,422 6,945 17,922 19,704 19,375 18,072 18,808 19,296 19,255
Noncurrent Deferred Revenue
6.00 179 208 273 340 409 429 553 361 347 317
Noncurrent Deferred & Payable Income Tax Liabilities
0.00 378 6.00 5.00 14 12 12 10 13 16 18
Other Noncurrent Operating Liabilities
- - - - 46 592 244 205 568 662 676
Commitments & Contingencies
0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- 0.00 1,000 1,000 1,004 968 968 965 968 895 203
Total Equity & Noncontrolling Interests
463 9,667 11,110 9,973 17,731 16,613 13,017 12,052 12,546 12,689 13,807
Total Preferred & Common Equity
457 9,654 11,092 9,813 17,559 16,349 12,772 23,028 12,309 12,454 13,576
Total Common Equity
457 9,654 11,092 9,813 17,559 16,349 12,772 23,028 12,309 12,454 13,576
Common Stock
457 9,654 11,092 9,827 - 16,364 12,787 23,045 12,317 12,458 13,579
Accumulated Other Comprehensive Income / (Loss)
- - - -14 -16 -15 -15 -17 -8.00 -4.00 -3.00
Noncontrolling Interest
6.00 13 18 146 156 249 245 241 237 235 231

Quarterly Balance Sheets for Mplx

This table presents Mplx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025
Total Assets
35,812 35,672 35,873 36,120 36,461 38,402 38,515 38,972 37,841
Total Current Assets
1,951 2,012 2,321 2,736 2,139 4,196 4,218 4,521 3,173
Cash & Equivalents
121 393 755 960 385 2,501 2,426 2,534 1,386
Accounts Receivable
1,639 1,415 1,371 1,592 1,555 1,495 1,584 1,768 1,562
Inventories, net
151 141 146 154 163 168 171 186 192
Other Current Assets
40 63 49 30 36 32 37 33 33
Plant, Property, & Equipment, net
18,910 18,758 18,692 18,620 19,299 0.00 19,153 19,147 0.00
Total Noncurrent Assets
14,951 15,130 15,088 14,764 15,023 34,206 15,144 15,304 34,668
Long-Term Investments
4,108 4,144 4,124 4,099 4,343 4,373 4,558 4,751 5,024
Goodwill
7,645 7,645 7,645 7,645 7,645 7,645 7,645 7,645 7,645
Intangible Assets
736 673 641 609 618 585 551 529 497
Other Noncurrent Operating Assets
1,240 2,668 2,678 2,411 2,417 21,603 2,390 2,379 21,502
Total Liabilities & Shareholders' Equity
35,812 35,672 35,873 36,120 36,461 38,402 38,515 38,972 37,841
Total Liabilities
22,169 22,624 22,684 22,804 22,814 24,516 24,533 24,904 23,792
Total Current Liabilities
2,499 1,312 1,316 1,399 2,960 4,226 4,267 4,169 3,069
Short-Term Debt
982 1.00 1.00 1.00 1,639 2,827 2,836 2,697 1,500
Accounts Payable
653 139 128 132 132 127 120 145 149
Accrued Expenses
411 424 390 472 414 418 461 480 515
Other Current Liabilities
261 883 886 607 588 602 630 644 638
Other Current Nonoperating Liabilities
192 192 247 187 187 252 220 203 267
Total Noncurrent Liabilities
19,670 21,312 21,368 21,405 19,854 20,290 20,266 20,735 20,723
Long-Term Debt
18,797 20,393 20,405 20,417 18,805 19,245 19,250 19,721 19,725
Noncurrent Deferred Revenue
300 347 381 414 482 344 326 317 308
Noncurrent Deferred & Payable Income Tax Liabilities
14 13 13 12 16 16 16 18 18
Other Noncurrent Operating Liabilities
241 559 569 562 551 685 674 679 672
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
967 968 968 970 561 202 203 0.00 0.00
Total Equity & Noncontrolling Interests
12,676 12,080 12,221 12,346 13,086 13,684 13,779 14,068 14,049
Total Preferred & Common Equity
26,357 11,843 11,984 12,110 12,852 13,451 13,547 13,838 13,820
Total Common Equity
12,438 11,843 11,984 12,110 12,852 13,451 13,547 13,838 13,820
Common Stock
26,303 11,847 11,988 12,114 12,855 13,454 13,550 13,833 13,815
Accumulated Other Comprehensive Income / (Loss)
-8.00 -4.00 -4.00 -4.00 -3.00 -3.00 -3.00 5.00 5.00
Noncontrolling Interest
238 237 237 236 234 233 232 230 229

Annual Metrics And Ratios for Mplx

This table displays calculated financial ratios and metrics derived from Mplx's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
63.17% 38.84% 175.11% 27.67% 81.15% 29.07% 1.11% 9.69% 15.82% -2.86% 5.78%
EBITDA Growth
64.10% 57.19% 152.49% 47.32% 88.72% 2.52% -54.45% 224.38% 16.17% -0.74% 7.41%
EBIT Growth
67.12% 51.23% 71.54% 79.30% 129.87% -10.92% -90.92% 1,791.94% 23.02% -0.22% 7.92%
NOPAT Growth
65.97% 55.69% 148.00% 26.28% 128.41% -12.52% -93.79% 2,601.91% 22.81% -0.30% 7.97%
Net Income Growth
63.70% 39.33% 170.27% -7.11% 139.95% -27.12% -146.99% 552.98% 27.83% -0.30% 9.86%
EPS Growth
48.06% -56.39% -100.00% 0.00% 116.04% -56.33% -180.00% 457.50% 31.12% 1.33% 10.79%
Operating Cash Flow Growth
57.55% 27.84% 249.18% 27.90% 61.04% 32.92% 10.75% 8.63% 2.20% 7.53% 10.17%
Free Cash Flow Firm Growth
138.49% -4,817.40% 95.80% 332.98% -1,505.08% 113.37% -19.12% 289.74% -37.13% 15.42% 20.64%
Invested Capital Growth
0.98% 1,054.02% 11.26% 0.80% 127.74% 1.10% -4.63% -7.80% 3.13% 0.86% -1.07%
Revenue Q/Q Growth
48.36% 8.82% 14.13% 6.53% 37.27% 0.00% 0.00% 70.18% -7.72% 2.77% 0.82%
EBITDA Q/Q Growth
38.23% 19.85% 16.19% 5.83% 21.67% 215.06% -30.48% 1,155.63% -1.15% 5.31% -0.21%
EBIT Q/Q Growth
34.58% 13.82% 15.93% 8.10% 23.71% 2,251.85% -78.58% 499.20% -1.25% 6.87% -0.60%
NOPAT Q/Q Growth
34.27% 17.51% 54.24% -10.62% 25.44% 0.00% 0.00% 499.34% -1.30% 6.69% -0.51%
Net Income Q/Q Growth
33.97% 9.43% 138.10% -32.74% 22.62% 0.00% 0.00% -57.50% -18.01% 8.78% -0.80%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 63.30% 0.00% 0.00% 8.88% -0.47%
Operating Cash Flow Q/Q Growth
42.01% 6.30% 30.33% 2.86% 18.30% 1.19% 2.10% 1.13% 2.62% 2.29% 3.23%
Free Cash Flow Firm Q/Q Growth
0.00% -4,871.25% 95.85% 299.68% -2,007.93% 112.29% -42.54% 140.86% 89.26% -14.51% 15.01%
Invested Capital Q/Q Growth
1.40% 976.82% 7.29% -0.05% 88.73% -3.44% 0.70% 5.47% -1.65% 2.09% -0.53%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
51.83% 59.04% 63.19% 56.09% 58.94% 58.94% 79.60% 57.78% 56.76% 58.71% 59.74%
EBITDA Margin
40.35% 45.69% 41.93% 48.38% 50.41% 40.04% 18.04% 53.35% 53.51% 54.68% 55.52%
Operating Margin
30.90% 34.60% 30.24% 30.80% 38.94% 26.29% 2.31% 39.81% 42.29% 43.44% 44.31%
EBIT Margin
30.77% 33.52% 20.90% 29.35% 37.24% 25.71% 2.31% 39.81% 42.29% 43.44% 44.31%
Profit (Net Income) Margin
30.14% 30.25% 29.71% 21.62% 28.64% 16.17% -7.52% 31.04% 34.25% 35.16% 36.51%
Tax Burden Percent
99.58% 99.70% 213.27% 99.88% 99.60% 100.00% 100.29% 99.97% 99.80% 99.72% 99.77%
Interest Burden Percent
98.36% 90.51% 66.67% 73.74% 77.19% 62.91% -324.64% 77.98% 81.16% 81.16% 82.58%
Effective Tax Rate
0.42% 0.30% -2.84% 0.12% 0.40% 0.00% 0.00% 0.03% 0.20% 0.28% 0.23%
Return on Invested Capital (ROIC)
22.68% 5.60% 7.15% 8.54% 11.85% 7.42% 0.47% 13.52% 17.04% 16.66% 18.00%
ROIC Less NNEP Spread (ROIC-NNEP)
20.95% 2.87% 5.31% -6.23% 3.04% 0.83% -4.85% 8.03% 11.08% 10.83% 12.08%
Return on Net Nonoperating Assets (RNNOA)
7.63% 0.97% 1.12% -1.29% 1.65% 0.63% -4.82% 9.53% 12.95% 12.62% 13.58%
Return on Equity (ROE)
30.31% 6.57% 8.27% 7.24% 13.50% 8.05% -4.35% 23.05% 29.99% 29.27% 31.58%
Cash Return on Invested Capital (CROIC)
21.70% -162.50% -3.51% 7.74% -66.10% 6.32% 5.21% 21.63% 13.96% 15.80% 19.08%
Operating Return on Assets (OROA)
20.14% 4.26% 3.77% 6.13% 8.87% 5.83% 0.55% 11.10% 13.80% 13.57% 14.28%
Return on Assets (ROA)
19.73% 3.85% 5.36% 4.52% 6.82% 3.67% -1.79% 8.65% 11.18% 10.99% 11.77%
Return on Common Equity (ROCE)
21.20% 6.56% 7.87% 6.56% 12.44% 7.52% -4.02% 30.56% 39.94% 26.75% 29.79%
Return on Equity Simple (ROE_SIMPLE)
52.30% 3.45% 8.11% 8.52% 11.42% 8.94% -5.38% 13.51% 32.32% 31.85% 32.09%
Net Operating Profit after Tax (NOPAT)
244 380 942 1,190 2,717 2,377 148 3,991 4,901 4,886 5,276
NOPAT Margin
30.77% 34.50% 31.10% 30.76% 38.79% 26.29% 1.62% 39.80% 42.20% 43.32% 44.21%
Net Nonoperating Expense Percent (NNEP)
1.73% 2.74% 1.84% 14.77% 8.81% 6.59% 5.32% 5.48% 5.95% 5.83% 5.92%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - 15.15% 14.75% 15.18%
Cost of Revenue to Revenue
48.17% 40.96% 36.81% 43.91% 41.06% 41.06% 20.40% 42.22% 43.24% 41.29% 40.26%
SG&A Expenses to Revenue
10.21% 11.35% 7.49% 6.23% 4.51% 4.29% 4.14% 3.52% 2.88% 3.36% 3.58%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
20.93% 24.43% 32.95% 25.29% 20.00% 32.65% 60.09% 17.97% 14.47% 15.27% 15.43%
Earnings before Interest and Taxes (EBIT)
244 369 633 1,135 2,609 2,324 211 3,992 4,911 4,900 5,288
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
320 503 1,270 1,871 3,531 3,620 1,649 5,349 6,214 6,168 6,625
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.58 0.16 0.57 0.81 0.79 1.04 1.28 1.07 2.21 2.67 3.53
Price to Tangible Book Value (P/TBV)
7.25 0.23 0.75 1.11 2.24 3.06 3.94 1.70 6.86 7.99 8.84
Price to Revenue (P/Rev)
3.22 1.39 2.08 2.05 1.98 1.88 1.79 2.46 2.34 2.94 4.01
Price to Earnings (P/E)
21.09 9.81 9.57 7.57 7.96 18.15 0.00 8.03 7.12 8.67 11.16
Dividend Yield
3.96% 9.12% 11.60% 11.58% 14.25% 16.53% 17.47% 11.43% 10.68% 11.92% 7.46%
Earnings Yield
4.74% 10.19% 10.45% 13.21% 12.56% 5.51% 0.00% 12.46% 14.05% 11.54% 8.96%
Enterprise Value to Invested Capital (EV/IC)
2.94 0.34 0.65 0.86 0.88 1.01 1.10 1.43 1.50 1.70 2.17
Enterprise Value to Revenue (EV/Rev)
4.00 3.90 2.98 3.10 3.99 3.61 3.68 4.04 3.77 4.43 5.30
Enterprise Value to EBITDA (EV/EBITDA)
9.92 8.54 7.11 6.41 7.92 9.01 20.42 7.57 7.05 8.10 9.54
Enterprise Value to EBIT (EV/EBIT)
13.01 11.65 14.27 10.57 10.72 14.03 159.60 10.14 8.92 10.20 11.95
Enterprise Value to NOPAT (EV/NOPAT)
13.01 11.31 9.59 10.09 10.30 13.72 228.01 10.14 8.94 10.22 11.98
Enterprise Value to Operating Cash Flow (EV/OCF)
9.51 10.07 6.06 6.29 9.11 7.99 7.45 8.24 8.73 9.26 10.63
Enterprise Value to Free Cash Flow (EV/FCFF)
13.60 0.00 0.00 11.13 0.00 16.09 20.55 6.34 10.92 10.78 11.30
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.39 0.54 0.37 0.63 0.96 1.12 1.44 1.43 1.46 1.50 1.50
Long-Term Debt to Equity
1.39 0.54 0.37 0.63 0.96 1.12 1.39 1.39 1.39 1.42 1.37
Financial Leverage
0.36 0.34 0.21 0.21 0.54 0.76 0.99 1.19 1.17 1.17 1.12
Leverage Ratio
1.54 1.71 1.54 1.60 1.98 2.20 2.43 2.66 2.68 2.66 2.68
Compound Leverage Factor
1.51 1.55 1.03 1.18 1.53 1.38 -7.90 2.08 2.18 2.16 2.22
Debt to Total Capital
58.18% 35.22% 26.75% 38.76% 48.89% 52.86% 59.02% 58.79% 59.43% 60.06% 59.92%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 2.24% 1.58% 2.97% 3.34% 4.84%
Long-Term Debt to Total Capital
58.18% 35.22% 26.75% 38.76% 48.89% 52.83% 56.78% 57.21% 56.46% 56.73% 55.08%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.54% 0.09% 6.16% 6.40% 3.16% 3.26% 3.55% 3.82% 3.62% 3.32% 1.24%
Common Equity to Total Capital
41.28% 64.70% 67.09% 54.77% 47.90% 43.84% 37.43% 72.90% 36.95% 36.61% 38.84%
Debt to EBITDA
2.01 10.45 3.48 3.71 5.08 5.45 12.21 3.47 3.19 3.31 3.16
Net Debt to EBITDA
1.93 5.48 1.35 1.57 3.67 3.98 9.76 2.73 2.49 2.54 2.25
Long-Term Debt to EBITDA
2.01 10.45 3.48 3.71 5.08 5.44 11.75 3.38 3.03 3.13 2.91
Debt to NOPAT
2.64 13.83 4.69 5.84 6.60 8.29 136.35 4.65 4.04 4.18 3.97
Net Debt to NOPAT
2.53 7.25 1.82 2.46 4.76 6.07 108.92 3.65 3.16 3.20 2.82
Long-Term Debt to NOPAT
2.64 13.83 4.69 5.84 6.60 8.29 131.18 4.53 3.84 3.95 3.65
Altman Z-Score
3.35 0.28 1.00 0.90 0.78 0.84 0.69 1.25 1.50 1.63 2.01
Noncontrolling Interest Sharing Ratio
30.05% 0.19% 4.73% 9.44% 7.86% 6.63% 7.75% -32.58% -33.19% 8.62% 5.67%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.96 0.92 1.14 0.43 0.63 0.70 0.73 0.45 0.79 1.07 1.01
Quick Ratio
0.77 0.76 1.02 0.35 0.30 0.29 0.55 0.39 0.71 1.00 0.95
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
233 -11,014 -463 1,079 -15,155 2,026 1,639 6,387 4,015 4,634 5,591
Operating Cash Flow to CapEx
236.88% 127.84% 113.64% 135.83% 146.03% 171.66% 401.15% 1,218.61% 695.15% 592.43% 563.60%
Free Cash Flow to Firm to Interest Expense
58.37 -314.69 -2.19 3.62 -25.47 2.35 1.83 8.05 4.34 5.02 6.07
Operating Cash Flow to Interest Expense
83.50 12.20 7.07 6.40 5.16 4.74 5.05 6.19 5.43 5.85 6.46
Operating Cash Flow Less CapEx to Interest Expense
48.25 2.66 0.85 1.69 1.63 1.98 3.79 5.68 4.65 4.86 5.31
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.65 0.13 0.18 0.21 0.24 0.23 0.24 0.28 0.33 0.31 0.32
Accounts Receivable Turnover
14.22 4.56 6.19 7.75 13.18 15.02 10.62 8.26 8.40 7.43 7.65
Inventory Turnover
32.37 14.32 21.04 28.30 35.29 35.69 16.36 32.56 34.63 30.35 28.34
Fixed Asset Turnover
0.80 0.20 0.28 0.33 0.42 0.41 0.42 0.49 0.00 0.00 0.00
Accounts Payable Turnover
9.88 5.04 5.99 3.80 6.17 14.61 4.97 3.44 4.62 24.71 32.03
Days Sales Outstanding (DSO)
25.66 80.06 58.93 47.10 27.69 24.30 34.38 44.17 43.44 49.13 47.70
Days Inventory Outstanding (DIO)
11.27 25.49 17.35 12.90 10.34 10.23 22.31 11.21 10.54 12.03 12.88
Days Payable Outstanding (DPO)
36.93 72.43 60.89 96.09 59.20 24.98 73.39 106.06 79.08 14.77 11.40
Cash Conversion Cycle (CCC)
0.01 33.12 15.39 -36.09 -21.17 9.55 -16.70 -50.68 -25.10 46.39 49.18
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,081 12,475 13,880 13,991 31,863 32,214 30,723 28,327 29,213 29,465 29,150
Invested Capital Turnover
0.74 0.16 0.23 0.28 0.31 0.28 0.29 0.34 0.40 0.38 0.41
Increase / (Decrease) in Invested Capital
11 11,394 1,405 111 17,872 351 -1,491 -2,396 886 252 -315
Enterprise Value (EV)
3,175 4,298 9,031 12,002 27,978 32,606 33,676 40,485 43,827 49,961 63,196
Market Capitalization
2,552 1,531 6,296 7,926 13,874 16,966 16,375 24,702 27,159 33,191 47,864
Book Value per Share
$6.06 $117.77 $30.84 $23.62 $22.11 $15.45 $12.28 $22.58 $12.27 $12.44 $13.33
Tangible Book Value per Share
$4.67 $80.73 $23.23 $17.13 $7.79 $5.24 $4.00 $14.26 $3.95 $4.15 $5.31
Total Capital
1,107 14,922 16,532 17,918 36,657 37,294 34,124 31,588 33,310 34,015 34,958
Total Debt
644 5,255 4,422 6,945 17,922 19,713 20,139 18,571 19,796 20,431 20,948
Total Long-Term Debt
644 5,255 4,422 6,945 17,922 19,704 19,375 18,072 18,808 19,296 19,255
Net Debt
617 2,754 1,717 2,930 12,944 14,423 16,088 14,577 15,463 15,640 14,898
Capital Expenditures (CapEx)
141 334 1,312 1,404 2,103 2,378 1,127 403 722 911 1,055
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-31 -92 -129 -750 -905 -654 178 -1,355 254 271 215
Debt-free Net Working Capital (DFNWC)
-4.00 -49 105 -745 -828 -639 193 -1,342 492 1,319 1,734
Net Working Capital (NWC)
-4.00 -49 105 -745 -828 -648 -571 -1,841 -496 184 41
Net Nonoperating Expense (NNE)
4.98 47 42 354 711 915 835 879 923 920 919
Net Nonoperating Obligations (NNO)
618 2,808 1,770 3,018 13,128 14,633 16,738 15,310 15,699 15,881 15,140
Total Depreciation and Amortization (D&A)
76 134 637 736 922 1,296 1,438 1,357 1,303 1,268 1,337
Debt-free, Cash-free Net Working Capital to Revenue
-3.91% -8.36% -4.26% -19.39% -12.92% -7.23% 1.95% -13.51% 2.19% 2.40% 1.80%
Debt-free Net Working Capital to Revenue
-0.50% -4.45% 3.47% -19.27% -11.82% -7.07% 2.11% -13.38% 4.24% 11.69% 14.53%
Net Working Capital to Revenue
-0.50% -4.45% 3.47% -19.27% -11.82% -7.17% -6.25% -18.36% -4.27% 1.63% 0.34%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $1.34 $0.00 $1.07 $2.29 $1.00 ($0.80) $2.86 $3.75 $3.80 $4.21
Adjusted Weighted Average Basic Shares Outstanding
75.90M 99M 676M 778M 1.52B 1.81B 2.10B 1.03B 1.01B 1.00B 1.02B
Adjusted Diluted Earnings per Share
$0.00 $1.33 $0.00 $1.06 $2.29 $1.00 ($0.80) $2.86 $3.75 $3.80 $4.21
Adjusted Weighted Average Diluted Shares Outstanding
75.90M 100M 690M 784M 1.52B 1.81B 2.10B 1.03B 1.01B 1.00B 1.02B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
75.90M 99M 0.00 0.00 761M 906M 1.05B 1.03B 1.01B 1.00B 1.02B
Normalized Net Operating Profit after Tax (NOPAT)
244 380 732 1,190 2,717 2,502 1,689 4,033 4,901 4,886 5,276
Normalized NOPAT Margin
30.77% 34.50% 24.17% 30.76% 38.79% 27.67% 18.48% 40.22% 42.20% 43.32% 44.21%
Pre Tax Income Margin
30.26% 30.34% 13.93% 21.64% 28.75% 16.17% -7.49% 31.05% 34.32% 35.25% 36.60%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
61.00 10.54 3.00 3.81 4.38 2.70 0.24 5.03 5.31 5.31 5.74
NOPAT to Interest Expense
60.99 10.85 4.46 3.99 4.57 2.76 0.16 5.03 5.30 5.29 5.73
EBIT Less CapEx to Interest Expense
25.75 1.00 -3.22 -0.90 0.85 -0.06 -1.02 4.53 4.53 4.32 4.60
NOPAT Less CapEx to Interest Expense
25.74 1.31 -1.75 -0.72 1.03 0.00 -1.09 4.52 4.52 4.31 4.58
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
73.22% 47.75% 97.00% 142.58% 95.06% 209.92% -442.94% 116.07% 77.55% 84.14% 83.70%
Augmented Payout Ratio
73.22% 47.75% 97.00% 142.58% 95.06% 209.92% -447.74% 136.31% 89.89% 84.14% 91.19%

Quarterly Metrics And Ratios for Mplx

This table displays calculated financial ratios and metrics derived from Mplx's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-4.93% 3.95% -8.50% -14.38% 11.42% 4.90% 13.46% 2.06% 3.27% 9.77% -1.61%
EBITDA Growth
-4.95% 8.48% 3.60% -26.42% 22.49% 4.77% 17.10% 9.74% -0.83% 7.65% -7.42%
EBIT Growth
-5.53% 12.83% 5.19% -31.06% 29.72% 4.60% 20.77% 10.49% -2.33% 9.19% -8.88%
NOPAT Growth
-5.75% 13.39% 5.19% -31.09% 29.02% 4.61% 20.56% 10.39% -2.00% 9.20% -8.81%
Net Income Growth
-1.67% 14.29% 6.56% -35.42% 38.84% 6.62% 25.90% 12.82% -3.06% 11.92% -10.79%
EPS Growth
0.00% 16.67% 9.64% -34.56% 39.74% 7.69% 26.37% 13.48% -1.83% 12.24% -10.43%
Operating Cash Flow Growth
10.32% 9.07% -3.36% 19.73% 8.85% 5.22% 8.91% 13.75% 12.49% -3.49% 10.93%
Free Cash Flow Firm Growth
-95.13% 79.06% -14.74% 270.24% 548.80% -69.16% -29.97% -58.34% 48.52% 116.52% 59.98%
Invested Capital Growth
3.13% -3.55% -0.55% -2.83% 0.86% 1.90% 1.67% 1.53% -1.07% -0.49% -0.70%
Revenue Q/Q Growth
-21.73% 1.92% -0.85% 8.25% 1.85% -4.05% 7.24% -2.62% 3.06% 1.99% -3.87%
EBITDA Q/Q Growth
-30.68% 9.11% -0.80% -1.94% 15.40% -6.67% 10.88% -8.10% 4.28% 1.31% -4.64%
EBIT Q/Q Growth
-36.68% 12.83% -1.76% -1.79% 19.15% -9.02% 13.43% -10.15% 5.33% 1.71% -5.34%
NOPAT Q/Q Growth
-36.79% 12.99% -1.65% -1.89% 18.35% -8.39% 13.35% -10.17% 5.06% 2.08% -5.35%
Net Income Q/Q Growth
-42.66% 15.53% -1.05% -1.49% 23.28% -11.28% 16.85% -11.72% 5.92% 2.43% -6.87%
EPS Q/Q Growth
-42.65% 16.67% 0.00% -2.20% 22.47% -10.09% 17.35% -12.17% 5.94% 2.80% -6.36%
Operating Cash Flow Q/Q Growth
31.67% -10.31% 17.11% -13.43% 19.69% -13.30% 21.22% -9.58% 18.37% -25.61% 39.33%
Free Cash Flow Firm Q/Q Growth
114.64% 1,219.90% -40.96% 49.23% -44.21% -37.27% 34.09% -11.23% 98.90% -8.55% -0.93%
Invested Capital Q/Q Growth
-1.65% -0.74% -0.49% 0.02% 2.09% 0.29% -0.72% -0.11% -0.53% 0.87% -0.93%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
16.38% 72.69% 85.99% 54.98% 24.85% 73.19% 86.60% 58.41% 21.78% 71.25% 70.76%
EBITDA Margin
51.95% 55.62% 55.65% 50.41% 57.11% 55.55% 57.44% 54.21% 54.85% 54.48% 54.05%
Operating Margin
39.82% 44.08% 43.68% 39.63% 46.36% 43.96% 46.49% 42.90% 43.85% 43.73% 43.06%
EBIT Margin
39.82% 44.08% 43.68% 39.63% 46.36% 43.96% 46.49% 42.90% 43.85% 43.73% 43.06%
Profit (Net Income) Margin
30.95% 35.09% 35.02% 31.87% 38.57% 35.66% 38.86% 35.23% 36.21% 36.36% 35.23%
Tax Burden Percent
99.76% 99.90% 100.00% 99.89% 99.22% 99.90% 99.83% 99.81% 99.55% 99.91% 99.91%
Interest Burden Percent
77.92% 79.68% 80.17% 80.50% 83.85% 81.22% 83.72% 82.27% 82.95% 83.24% 81.90%
Effective Tax Rate
0.24% 0.10% 0.00% 0.11% 0.78% 0.10% 0.17% 0.19% 0.45% 0.09% 0.09%
Return on Invested Capital (ROIC)
16.03% 17.47% 17.31% 14.84% 17.69% 17.12% 18.79% 17.43% 17.77% 18.10% 17.90%
ROIC Less NNEP Spread (ROIC-NNEP)
14.53% 16.00% 15.83% 13.42% 16.29% 15.65% 17.30% 15.96% 16.30% 16.63% 16.36%
Return on Net Nonoperating Assets (RNNOA)
16.98% 20.28% 19.01% 15.73% 18.99% 18.67% 19.89% 18.05% 18.33% 18.75% 17.89%
Return on Equity (ROE)
33.02% 37.75% 36.32% 30.57% 36.67% 35.79% 38.67% 35.48% 36.10% 36.85% 35.78%
Cash Return on Invested Capital (CROIC)
13.96% 20.69% 18.18% 18.51% 15.80% 14.99% 16.16% 16.71% 19.08% 18.78% 18.72%
Operating Return on Assets (OROA)
12.99% 14.47% 13.98% 12.10% 14.49% 13.91% 14.74% 13.61% 14.13% 14.16% 13.74%
Return on Assets (ROA)
10.10% 11.52% 11.21% 9.73% 12.05% 11.29% 12.32% 11.17% 11.67% 11.77% 11.24%
Return on Common Equity (ROCE)
43.97% 34.26% 32.99% 27.84% 33.51% 33.11% 36.33% 33.35% 34.05% 35.48% 34.93%
Return on Equity Simple (ROE_SIMPLE)
0.00% 34.59% 34.67% 30.11% 0.00% 31.35% 31.77% 32.42% 0.00% 32.36% 0.00%
Net Operating Profit after Tax (NOPAT)
1,057 1,195 1,175 1,153 1,364 1,250 1,417 1,273 1,337 1,365 1,292
NOPAT Margin
39.72% 44.04% 43.68% 39.59% 46.00% 43.91% 46.42% 42.82% 43.65% 43.69% 43.02%
Net Nonoperating Expense Percent (NNEP)
1.51% 1.47% 1.48% 1.42% 1.40% 1.47% 1.48% 1.46% 1.47% 1.46% 1.53%
Return On Investment Capital (ROIC_SIMPLE)
3.27% - - - 4.12% - - - 3.85% 3.74% 3.66%
Cost of Revenue to Revenue
83.62% 27.31% 14.01% 45.02% 75.15% 26.81% 13.40% 41.59% 78.22% 28.75% 29.24%
SG&A Expenses to Revenue
3.27% 3.28% 3.31% 3.50% 3.34% 3.83% 3.51% 3.60% 3.40% 3.59% 3.56%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
-23.44% 28.60% 42.30% 15.35% -21.51% 29.23% 40.10% 15.51% -22.07% 27.53% 27.71%
Earnings before Interest and Taxes (EBIT)
1,060 1,196 1,175 1,154 1,375 1,251 1,419 1,275 1,343 1,366 1,293
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,383 1,509 1,497 1,468 1,694 1,581 1,753 1,611 1,680 1,702 1,623
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.21 2.66 2.59 2.70 2.67 3.24 3.22 3.35 3.53 3.95 3.80
Price to Tangible Book Value (P/TBV)
6.86 8.94 8.41 8.47 7.99 9.07 8.29 8.48 8.84 9.66 9.26
Price to Revenue (P/Rev)
2.34 2.69 2.71 2.97 2.94 3.65 3.68 3.83 4.01 4.48 4.32
Price to Earnings (P/E)
7.12 7.75 7.52 8.99 8.67 10.38 10.14 10.30 11.16 12.38 12.23
Dividend Yield
10.68% 9.41% 9.76% 9.51% 11.92% 7.82% 7.81% 7.65% 7.46% 6.75% 7.22%
Earnings Yield
14.05% 12.91% 13.29% 11.12% 11.54% 9.63% 9.86% 9.71% 8.96% 8.08% 8.17%
Enterprise Value to Invested Capital (EV/IC)
1.50 1.67 1.66 1.71 1.70 1.97 2.01 2.08 2.17 2.38 2.32
Enterprise Value to Revenue (EV/Rev)
3.77 4.14 4.17 4.48 4.43 5.09 5.00 5.15 5.30 5.74 5.56
Enterprise Value to EBITDA (EV/EBITDA)
7.05 7.67 7.49 8.40 8.10 9.31 9.07 9.17 9.54 10.39 10.22
Enterprise Value to EBIT (EV/EBIT)
8.92 9.62 9.37 10.73 10.20 11.73 11.33 11.45 11.95 12.97 12.82
Enterprise Value to NOPAT (EV/NOPAT)
8.94 9.63 9.38 10.74 10.22 11.76 11.37 11.49 11.98 13.00 12.84
Enterprise Value to Operating Cash Flow (EV/OCF)
8.73 9.48 9.43 9.33 9.26 10.64 10.54 10.58 10.63 11.88 11.14
Enterprise Value to Free Cash Flow (EV/FCFF)
10.92 7.95 9.09 9.08 10.78 13.24 12.53 12.53 11.30 12.66 12.36
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.46 1.56 1.55 1.53 1.50 1.50 1.59 1.58 1.50 1.59 1.51
Long-Term Debt to Equity
1.39 1.56 1.55 1.53 1.42 1.38 1.39 1.38 1.37 1.40 1.40
Financial Leverage
1.17 1.27 1.20 1.17 1.17 1.19 1.15 1.13 1.12 1.13 1.09
Leverage Ratio
2.68 2.74 2.73 2.67 2.66 2.70 2.74 2.73 2.68 2.72 2.73
Compound Leverage Factor
2.09 2.18 2.18 2.15 2.23 2.19 2.30 2.25 2.23 2.27 2.24
Debt to Total Capital
59.43% 60.98% 60.74% 60.53% 60.06% 59.97% 61.38% 61.23% 59.92% 61.44% 60.17%
Short-Term Debt to Total Capital
2.97% 0.00% 0.00% 0.00% 3.34% 4.81% 7.86% 7.86% 4.84% 7.39% 4.25%
Long-Term Debt to Total Capital
56.46% 60.98% 60.74% 60.52% 56.73% 55.16% 53.52% 53.37% 55.08% 54.05% 55.92%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.62% 3.60% 3.59% 3.58% 3.32% 2.33% 1.21% 1.21% 1.24% 0.63% 0.65%
Common Equity to Total Capital
36.95% 35.41% 35.67% 35.90% 36.61% 37.70% 37.41% 37.56% 38.84% 37.93% 39.18%
Debt to EBITDA
3.19 3.22 3.20 3.49 3.31 3.28 3.40 3.33 3.16 3.32 3.21
Net Debt to EBITDA
2.49 2.50 2.43 2.62 2.54 2.52 2.34 2.27 2.25 2.24 2.24
Long-Term Debt to EBITDA
3.03 3.22 3.20 3.49 3.13 3.01 2.96 2.90 2.91 2.92 2.98
Debt to NOPAT
4.04 4.04 4.00 4.46 4.18 4.14 4.26 4.16 3.97 4.16 4.03
Net Debt to NOPAT
3.16 3.14 3.04 3.35 3.20 3.18 2.93 2.85 2.82 2.81 2.81
Long-Term Debt to NOPAT
3.84 4.04 4.00 4.46 3.95 3.81 3.71 3.63 3.65 3.66 3.75
Altman Z-Score
1.14 1.30 1.28 1.31 1.31 1.49 1.49 1.52 1.66 1.76 1.76
Noncontrolling Interest Sharing Ratio
-33.19% 9.25% 9.16% 8.94% 8.62% 7.49% 6.06% 6.01% 5.67% 3.70% 2.38%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.79 1.53 1.76 1.96 1.07 0.72 0.99 0.99 1.01 1.08 1.03
Quick Ratio
0.71 1.38 1.62 1.82 1.00 0.66 0.95 0.94 0.95 1.03 0.96
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
171 2,263 1,336 1,994 1,112 698 936 831 1,652 1,511 1,497
Operating Cash Flow to CapEx
524.14% 726.04% 546.39% 557.85% 543.43% 506.27% 734.74% 505.36% 545.60% 468.42% 576.74%
Free Cash Flow to Firm to Interest Expense
0.68 9.31 5.73 8.86 5.01 2.97 4.05 3.68 7.21 6.60 6.40
Operating Cash Flow to Interest Expense
5.41 5.05 6.17 5.53 6.71 5.49 6.77 6.26 7.31 5.44 7.42
Operating Cash Flow Less CapEx to Interest Expense
4.38 4.35 5.04 4.54 5.47 4.41 5.85 5.02 5.97 4.28 6.13
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.33 0.33 0.32 0.31 0.31 0.32 0.32 0.32 0.32 0.32 0.32
Accounts Receivable Turnover
8.40 7.89 7.93 6.79 7.43 7.69 8.22 7.45 7.65 7.35 7.96
Inventory Turnover
34.63 34.19 28.30 30.52 30.35 30.79 30.01 28.54 28.34 28.30 27.93
Fixed Asset Turnover
0.00 0.61 0.00 0.59 0.00 0.60 0.00 0.63 0.00 0.64 0.00
Accounts Payable Turnover
4.62 28.09 9.71 11.86 24.71 34.54 36.96 36.80 32.03 35.65 36.43
Days Sales Outstanding (DSO)
43.44 46.25 46.02 53.72 49.13 47.49 44.42 48.97 47.70 49.66 45.87
Days Inventory Outstanding (DIO)
10.54 10.68 12.90 11.96 12.03 11.85 12.16 12.79 12.88 12.90 13.07
Days Payable Outstanding (DPO)
79.08 13.00 37.59 30.78 14.77 10.57 9.88 9.92 11.40 10.24 10.02
Cash Conversion Cycle (CCC)
-25.10 43.93 21.32 34.90 46.39 48.77 46.70 51.84 49.18 52.33 48.92
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
29,213 28,998 28,855 28,862 29,465 29,550 29,336 29,304 29,150 29,404 29,131
Invested Capital Turnover
0.40 0.40 0.40 0.37 0.38 0.39 0.40 0.41 0.41 0.41 0.42
Increase / (Decrease) in Invested Capital
886 -1,068 -161 -841 252 552 481 442 -315 -146 -205
Enterprise Value (EV)
43,827 48,562 47,824 49,210 49,961 58,122 58,913 60,912 63,196 70,088 67,626
Market Capitalization
27,159 31,500 31,092 32,645 33,191 41,611 43,280 45,375 47,864 54,725 52,582
Book Value per Share
$12.27 $11.83 $11.97 $12.10 $12.44 $12.75 $13.24 $13.27 $13.33 $13.53 $13.54
Tangible Book Value per Share
$3.95 $3.52 $3.69 $3.85 $4.15 $4.55 $5.14 $5.24 $5.31 $5.54 $5.56
Total Capital
33,310 33,442 33,595 33,734 34,015 34,091 35,958 36,068 34,958 36,486 35,274
Total Debt
19,796 20,394 20,406 20,418 20,431 20,444 22,072 22,086 20,948 22,418 21,225
Total Long-Term Debt
18,808 20,393 20,405 20,417 19,296 18,805 19,245 19,250 19,255 19,721 19,725
Net Debt
15,463 15,857 15,527 15,359 15,640 15,716 15,198 15,102 14,898 15,133 14,815
Capital Expenditures (CapEx)
261 169 263 223 274 255 213 280 307 266 301
Debt-free, Cash-free Net Working Capital (DFCFNWC)
254 308 251 378 271 433 296 361 215 515 218
Debt-free Net Working Capital (DFNWC)
492 701 1,006 1,338 1,319 818 2,797 2,787 1,734 3,049 1,604
Net Working Capital (NWC)
-496 700 1,005 1,337 184 -821 -30 -49 41 352 104
Net Nonoperating Expense (NNE)
233 243 233 225 220 235 231 226 228 229 234
Net Nonoperating Obligations (NNO)
15,699 15,950 15,666 15,546 15,881 15,903 15,450 15,322 15,140 15,336 15,082
Total Depreciation and Amortization (D&A)
323 313 322 314 319 330 334 336 337 336 330
Debt-free, Cash-free Net Working Capital to Revenue
2.19% 2.63% 2.19% 3.44% 2.40% 3.79% 2.51% 3.05% 1.80% 4.22% 1.79%
Debt-free Net Working Capital to Revenue
4.24% 5.98% 8.77% 12.19% 11.69% 7.17% 23.75% 23.55% 14.53% 24.97% 13.19%
Net Working Capital to Revenue
-4.27% 5.97% 8.77% 12.18% 1.63% -7.19% -0.25% -0.41% 0.34% 2.88% 0.86%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.78 $0.91 $0.91 $0.89 $1.09 $0.98 $1.15 $1.01 $1.07 $1.10 $1.03
Adjusted Weighted Average Basic Shares Outstanding
1.01B 1.00B 1.00B 1.00B 1.00B 1.01B 1.02B 1.02B 1.02B 1.02B 1.02B
Adjusted Diluted Earnings per Share
$0.78 $0.91 $0.91 $0.89 $1.09 $0.98 $1.15 $1.01 $1.07 $1.10 $1.03
Adjusted Weighted Average Diluted Shares Outstanding
1.01B 1.00B 1.00B 1.00B 1.00B 1.01B 1.02B 1.02B 1.02B 1.02B 1.02B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.01B 1.00B 1.00B 1.00B 1.00B 1.01B 1.02B 1.02B 1.02B 1.02B 1.02B
Normalized Net Operating Profit after Tax (NOPAT)
1,057 1,195 823 1,153 1,364 1,250 1,417 1,273 1,337 1,365 1,292
Normalized NOPAT Margin
39.72% 44.04% 30.58% 39.59% 46.00% 43.91% 46.42% 42.82% 43.65% 43.69% 43.02%
Pre Tax Income Margin
31.03% 35.13% 35.02% 31.90% 38.87% 35.70% 38.93% 35.30% 36.37% 36.40% 35.26%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.19 4.92 5.04 5.13 6.19 5.32 6.14 5.64 5.86 5.97 5.53
NOPAT to Interest Expense
4.18 4.92 5.04 5.12 6.15 5.32 6.13 5.63 5.84 5.96 5.52
EBIT Less CapEx to Interest Expense
3.16 4.23 3.91 4.14 4.96 4.24 5.22 4.40 4.52 4.80 4.24
NOPAT Less CapEx to Interest Expense
3.15 4.22 3.91 4.13 4.91 4.23 5.21 4.39 4.50 4.80 4.23
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
77.55% 76.86% 77.30% 89.33% 84.14% 84.21% 81.21% 80.69% 83.70% 83.72% 88.53%
Augmented Payout Ratio
89.89% 86.40% 85.87% 94.16% 84.14% 86.08% 84.72% 85.84% 91.19% 91.56% 97.17%

Key Financial Trends

MPLX LP has demonstrated consistent financial performance and growth over the last four years through its quarterly reports ending Q2 2025. Here are key takeaways and trends from the income statements, balance sheets, and cash flow statements analyzed:

  • Steady Revenue Growth: Operating revenue rose from approximately $2.71 billion in Q1 2023 to $3.00 billion in Q2 2025, indicating steady top-line growth.
  • Improving Net Income: Consolidated net income increased from roughly $915 million in Q1 2023 to $1.058 billion in Q2 2025, showing improved profitability across periods.
  • Strong Operating Cash Flow: Net cash from operating activities consistently stayed robust, peaking at $1.736 billion in Q2 2025. This reflects strong cash generation from core business operations.
  • Capital Investment Supporting Growth: Sustained purchases of property, plant, and equipment (around $200-$300 million quarterly) suggest ongoing reinvestment in assets to support business expansion and operations.
  • Managed Debt Behavior: Although long-term debt remains elevated near $19.7 billion in Q2 2025, there have been sizeable repayments (e.g., $1.2 billion in Q2 2025) indicating disciplined management of leverage.
  • Consistent Dividend Payments: Dividends remain steady around $0.95 per share quarterly, reflecting a commitment to returning capital to shareholders.
  • Large Goodwill and Intangible Assets: Goodwill is about $7.6 billion consistently, with intangible assets near $500 million to $600 million, indicating significant past acquisitions but posing valuation risk if impaired.
  • Stable Share Count: Weighted average diluted shares outstanding have remained steady around 1.02 billion shares, indicating limited dilution from equity issuance.
  • Negative Net Investing Cash Flow: Significant cash outflows in investing activities (e.g., $602 million in Q2 2025) mainly from acquisitions and capital expenditures could pressure liquidity if not balanced by operating cash flow.
  • Large Dividends and Buybacks Impact Financing Cash Flow: Financing activities show large outflows (e.g., $2.282 billion in Q2 2025) driven by debt repayments, dividend payments, and stock repurchases, which may strain cash reserves if continuing aggressively.

In summary, MPLX LP is showing solid revenue and earnings growth, backed by strong operating cash flow and disciplined debt management. However, attention should be paid to the sizeable capital expenditure and financing outflows, which may elevate liquidity risk if operating performance weakens. The company’s steady dividend payouts and stable share base support investor returns, though the high goodwill balance warrants monitoring for potential impairment risk.

08/18/25 04:45 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Mplx's Financials

When does Mplx's fiscal year end?

According to the most recent income statement we have on file, Mplx's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Mplx's net income changed over the last 10 years?

Mplx's net income appears to be on an upward trend, with a most recent value of $4.36 billion in 2024, rising from $239 million in 2014. The previous period was $3.97 billion in 2023. Find out what analysts predict for Mplx in the coming months.

What is Mplx's operating income?
Mplx's total operating income in 2024 was $5.29 billion, based on the following breakdown:
  • Total Gross Profit: $7.13 billion
  • Total Operating Expenses: $1.84 billion
How has Mplx's revenue changed over the last 10 years?

Over the last 10 years, Mplx's total revenue changed from $793 million in 2014 to $11.93 billion in 2024, a change of 1,404.8%.

How much debt does Mplx have?

Mplx's total liabilities were at $23.50 billion at the end of 2024, a 2.4% increase from 2023, and a 3,029.3% increase since 2014.

How much cash does Mplx have?

In the past 10 years, Mplx's cash and equivalents has ranged from $5 million in 2017 to $1.52 billion in 2024, and is currently $1.52 billion as of their latest financial filing in 2024.

How has Mplx's book value per share changed over the last 10 years?

Over the last 10 years, Mplx's book value per share changed from 6.06 in 2014 to 13.33 in 2024, a change of 119.9%.



This page (NYSE:MPLX) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners